Today ContextVision held a company presentation at Danske Bank's Small & Mid Cap Seminar in Stockholm, Sweden.CEO Anita Tollstadius gave an update of the company's development and shared the company's future direction.
ContextVision to showcase Altumira(TM), AI-powered image enhancement for digital radiography at ECR 2019
Demonstrations available at booth 111 in EXPO X1 STOCKHOLM – Feb. 20, 2019 – At this year’s European Congress of Radiology (ECR) in Vienna, ContextVision will show Altumira, its latest image enhancement platform. With deep learning technology integrated, Altumira is specially designed to meet the demanding needs of digital radiography for both dynamic and static […]
With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest image enhancement platform, Altumira(TM).
After over 8 years as the CEO at ContextVision, Anita Tollstadius has informed the Board of Directors that she wishes to retire during 2019, to spend more time with her family.
Stockholm, September 24th, 2018 – An update on ContextVision has been published in the Swedish online magazine Investeringstipset (in Swedish only). Please find a link here. For further information, please contact ContextVision’s CEO, Anita Tollstadius, at +46 70 337 30 26 or visit www.contextvision.com. About ContextVision ContextVision is a medical technology software company that specializes […]
September 6, 2018, – ContextVision is making their second appearance in the field of digital pathology at ECP 2018, the 30th European Congress of Pathology, September 8–12 in Bilbao, Spain. Here, they will be introducing and demonstrating their upcoming product INIFY™ Prostate, a new decision support tool based on artificial intelligence and deep learning.
ContextVision recently made their first appearance in the field of digital pathology at ECDP/NDP 2018 – the 14th European Congress on Digital Pathology and the 5th Nordic Symposium on Digital Pathology, held in Helsinki, Finland, end of May.